National Health Correlations

NHI Stock  USD 64.97  0.38  0.59%   
The correlation of National Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as National Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if National Health Investors moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Weak diversification

The correlation between National Health Investors and NYA is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding National Health Investors and NYA in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
  
The ability to find closely correlated positions to National Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace National Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back National Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling National Health Investors to buy it.

Moving together with National Stock

  0.85O Realty Income Corp Sell-off TrendPairCorr
  0.85HR Healthcare Realty TrustPairCorr
  0.86ELME Elme CommunitiesPairCorr
  0.95EPRT Essential PropertiesPairCorr
  0.82WELL WelltowerPairCorr
  0.76AAT American Assets TrustPairCorr
  0.84ADC Agree RealtyPairCorr
  0.69AHR American Healthcare REITPairCorr
  0.76AIV Apartment Investment andPairCorr

Moving against National Stock

  0.76FR First Industrial RealtyPairCorr
  0.75WHLR Wheeler Real EstatePairCorr
  0.7AHT Ashford Hospitality TrustPairCorr
  0.65WY Weyerhaeuser Financial Report 25th of July 2024 PairCorr
  0.63EQIX EquinixPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
HRVTR
HRDOC
UHTGMRE
VTRDOC
SBRAOHI
OHIVTR
  
High negative correlations   
CHCTHR
CHCTDOC
CHCTVTR
PEAKVTR
HRPEAK
GMRE-PACHCT

Risk-Adjusted Indicators

There is a big difference between National Stock performing well and National Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze National Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GMRE  1.34 (0.10) 0.00 (0.02) 0.00 
 2.77 
 7.67 
DOC  1.22  0.16  0.12  0.13  1.27 
 2.44 
 7.64 
VTR  1.08  0.07  0.06  0.08  1.33 
 2.02 
 8.14 
OHI  0.74  0.00  0.00  0.04  0.98 
 1.89 
 5.66 
PEAK  106.37  50.26  3.08  0.83  10.01 
 4.76 
 102.41 
HR  1.22  0.23  0.16  0.22  1.26 
 2.79 
 7.98 
SBRA  0.97  0.04  0.04  0.08  1.13 
 1.91 
 5.64 
CHCT  1.16 (0.32) 0.00 (0.23) 0.00 
 2.08 
 8.60 
UHT  1.40 (0.18) 0.00 (0.11) 0.00 
 3.19 
 8.41 
GMRE-PA  0.47  0.04  0.00  0.40  0.45 
 0.86 
 2.73 

Be your own money manager

Our tools can tell you how much better you can do entering a position in National Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module

National Health Corporate Directors

National Health corporate directors refer to members of a National Health board of directors. The board of directors generally takes responsibility for the National Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of National Health's board members must vote for the resolution. The National Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Robert AdamsIndependent DirectorProfile
James JobeIndependent DirectorProfile
Robert WebbIndependent DirectorProfile
Dana HamblyDirector of Investor RelationsProfile

Already Invested in National Health Investors?

The danger of trading National Health Investors is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of National Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than National Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile National Health Investors is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for National Stock analysis

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.14)
Dividend Share
3.6
Earnings Share
3.05
Revenue Per Share
7.368
Quarterly Revenue Growth
(0.12)
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.